Answers are grounded in this paper and cite their sources.
Untreated high viral load HBeAg-negative CHB patients without significant ALT elevation had higher risks of clinical events than treated Active phase patients with elevated ALT.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: